Core Insights - Cardiac Biotech Solutions, Inc. (CBSC) has received a Medical Device License from Health Canada for its MyCardia AT device, now rebranded as CardioHolter AT, allowing for immediate import into Canada [1] - The initial order from exclusive Canadian distributor Your Heart Protector Corp. amounts to $375,000 USD for 1,000 devices, with delivery expected within 90-120 days [2] - CBSC has introduced a monthly rental program for its devices, generating recurring income through usage fees shared with distributor partners [3] Company Overview - CBSC specializes in non-invasive ambulatory cardiac monitoring products, with a focus on advanced cardiac monitoring solutions [5] - The company aims to enhance patient outcomes through innovative technology that allows for remote monitoring and timely diagnosis of heart conditions [4] - CBSC's MyCardia AT platform integrates wearable technology with AWS Cloud-based connectivity and mobile applications, with regulatory approvals in the US, Canada, and ongoing submissions in China [4] Distributor and Partner Information - Your Heart Protector Corp. is the exclusive distributor for CBSC in Canada, focusing on remote diagnostic testing and innovative cardiac monitoring solutions [6] - Nasiff Associates, CBSC's manufacturing partner, is a licensed establishment in Canada, ensuring compliance with Health Canada standards for Class II medical devices [1][7]